Blood bank reagents option year 3 order
Ended Awarded Last action
- Contract number
- 36C25725N0200
- Awardee
-
Alba Bioscience, Inc. UEI V6KNKL6BDHL7
- Awarding agency
-
Veterans Integrated Service Network 17
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $7,634
Award facts
- Contract value 100% obligated
- $7,634.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Chicago, IL 60607, USA
Award details come from SAM.gov/FPDS.
About this award
Alba Bioscience, Inc., a Chicago-based supplier of immunohematology reagents and blood banking materials, received a Blanket Purchase Agreement call order valued at $7,634.01 for blood bank reagents under Option Year 3. The award was issued by Veterans Integrated Service Network 17 on May 1, 2025, with a completion date of April 30, 2026, under a firm fixed-price contract structure with no set-aside designation. This order falls under Alba Bioscience's existing GSA Schedule 65-VII contract for In Vitro Diagnostics, Reagents, and Tests, leveraging the company's established position as a critical supplier of specialized blood banking products to the Department of Veterans Affairs.
Alba Bioscience's deliverables under this procurement include its comprehensive portfolio of monoclonal antibodies, antibody identification and screening panels, quality control kits, and blood bank additives—products essential for blood typing, antibody screening, and transfusion services across VA medical facilities. As a non-small business competing without set-aside protections, Alba Bioscience has demonstrated sustained demand across multiple VA networks and federal agencies including the Defense Logistics Agency and National Institutes of Health. The company's two primary BPAs with the VA extend through 2030 and 2026 respectively, with task orders issued by multiple Veterans Integrated Service Networks, reflecting broad utilization across the VA's integrated healthcare system to support diagnostic testing and transfusion services nationwide.
Quick answers
Who was awarded contract 36C25725N0200?
36C25725N0200 was awarded to Alba Bioscience, Inc. by Veterans Integrated Service Network 17 (Veterans Health Administration) on May 1, 2025.
How much is contract 36C25725N0200 worth?
The government has obligated $7,634 on 36C25725N0200.
Is contract 36C25725N0200 an order under another contract?
Yes. 36C25725N0200 is a BPA call under 36F79721D0259-36C25722A0011, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25725N0200 competed?
The extent of competition for 36C25725N0200 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award